Dual Effects of LPS Antibodies on Cellular Uptake of LPS and LPS-Induced Proinflammatory Functions

Journal of Immunology

Volumn 159, Issue 7, 1997, Pages 3519-3530

  Pollack, Matthew ^a   Ohl, Christopher A ^a,e   Golenbock, Douglas T ^b   Di Padova, Franco ^c   Wahl, Larry M ^d   Koles, Nancy L ^a   Guelde, Gretchen ^a   Monks, Brian G ^b  

^a Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^b Maxwell Finland Lab Infect Dis   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

^d NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^e EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; CD14 ANTIGEN; COMPLEMENT COMPONENT C3B RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY;

ADULT; ANIMAL; ARTICLE; BLOOD; CHEMISTRY; CHO CELL; COMPARATIVE STUDY; FIBROBLAST; HAMSTER; HUMAN; IMMUNOLOGY; INFLAMMATION; METABOLISM; MONOCYTE; PATHOLOGY; PROTEIN CONFORMATION; TRANSPORT AT THE CELLULAR LEVEL;

ADULT; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; ANTIGENS, BACTERIAL; ANTIGENS, CD14; BIOLOGICAL TRANSPORT; CHO CELLS; CRICETINAE; FIBROBLASTS; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; MONOCYTES; NF-KAPPA B; PROTEIN CONFORMATION; RECEPTORS, COMPLEMENT 3B;

EID: 0031252289     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Ulevitch, R. J., and P. S. Tobias. 1994. Recognition of endotoxin by cells leading to transmembrane signaling. Curr. Opin. Immunol. 6:125.
2. Kitchens, R. L., and R. S. Munford. 1995. Enzymatically deacylated lipopolysaccharide (LPS) can antagonize LPS at multiple sites in the LPS recognition pathway. J. Biol. Chem. 270:9904.
3. Tobias, P. S., and R. J. Ulevitch. 1993. Lipopolysaccharide binding protein and CD14 in LPS dependent macrophage activation. Immunobiology 187:227.
4. Hailman, E., H. S. Lichenstein, M. M. Wurfel, D. S. Miller, D. A. Johnson, M. Kelley, L. A. Busse, M. M. Zukowski, and S. D. Wrighi. 1994. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J. Exp. Med. 179:269.
5. Gegner, J. A., R. J. Ulevitch, and P. S. Tobias. 1995. Lipopolysaccharide (LPS) signal transduction and clearance: dual roles for LPS binding protein and membrane CD14. J. Biol. Chem. 270:5320.
6. Pollack, M. 1992. Specificity and function of lipopolysaccharide antibodies. In Bacterial Endotoxic Lipopolysaccharides. Volume II. Immunopharmacology and Pathophysiology. J. L. Ryan and D. C. Morrison, eds. CRC Press, Boca Raton, p. 347.
7. Pollack, M., N. L. Koles, M. E. Evans, D. Panopoulos, K. Oishi, M. Tao, M. Akiyama, and W. D. Hoffman. 1993. Antibacterial and antiendotoxic actions and interactions of lipopolysaccharide antibodies and complement. In Bacterial Endotoxin: Recognition and Effector Mechanisms. J. Levin, C. R. Alving, R. S. Munford, and P. L. Stütz, eds. Elsevier Science Publishers B. V., Amsterdam, p. 113.
8. Weersink, A. J. L., K. P. M. van Kessel, R. Torensma, J. A. G. van Strijp, and J. Verhoef. 1990. Binding of rough lipopolysaccharides (LPS) to human leukocytes: inhibition by anti-LPS monoclonal antibody. J. Immunol. 145:318.
9. Lasfargues, A., M. Tahri-Jouti, T. Pedron, R. Girard, and R. Chaby. 1989. Effects of lipopolysaccharide on macrophages analyzed with anti-lipid A monoclonal antibodies and polymyxin B. Eur. J. Immunol. 192:219.
10. Heumann, D., P. Gallay, C. Barras, P. Zaech, R. J. Ulevitch, P. S. Tobias, M.-P. Glauser, and J. D. Baumgartner. 1992. Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes. J. Immunol. 148:3505.
11. Burd, R. S., R. J. Battafarano, C. S. Cody, M. S. Farber, C. A. Ratz, and D. L. Dunn. 1993. Anti-endotoxin monoclonal antibodies inhibit secretion of tumor necrosis factor-α by two distinct mechanisms. Ann. Surg. 218:250.
12. Tahri-Jouti, M.-A., M. Mondange, A. Le Dur, F.-I. Auzanneau, D. Charon, R. Girard, and R. Chaby. 1990. Specific binding of lipopolysaccharides to mouse macrophages. II. Involvement of distinct lipid A substructures. Mol. Immunol. 27:763.
13. Di Padova, F. E., H. Brade, G. R. Barclay, I. R. Poxton, E. Liehl, E. Schuetze, H. P. Kocher, G. Ramsay, M. H. Schreier, D. B. McClelland, and E. T. Rietschel. 1993. A broadly cross-protective monoclonal antibody binding to Escherichia coli and Salmonella lipopolysaccharide. Infect. Immun. 613863.
14. Di Padova, F. E., V. Mikol, G. R. Barclay, I. R. Poxton, H. Brade, and E. T. Rietschel. 1994. Anti-lipopolysaccharide core antibodies. Prog. Clin. Biol. Res. 388:85.
15. Pollack, M., A. M. Espinoza, G. Guelde, N. L. Koles, L. M. Wahl, and C. A. OhI. 1995. Lipopolysaccharide (LPS)-specific monoclonal antibodies regulate LPS uptake and LPS-induced tumor necrosis factor-a responses by human monocytes. J. Infect. Dis. 172:794.
16. Kitchens, R. L., R. J. Ulevitch, and R. S. Munford. 1992. Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway. J. Exp. Med. 176: 485.
17. Golenbock, D. T., Y. Liu, F. H. Millham, M. W. Freeman, and R. A. Zoeller. 1993. Surface expression of human CD14 in Chinese hamster ovary fibroblasts imparts macrophage-like responsiveness to bacterial endoloxin. J. Biol. Chem. 268:22055.
18. Skelly, R. R., P. Munkenbeck, and D. C. Morrison. 1979. Stimulation of T-independent antibody responses by hapten-lipopolysaccharides without repeating polymeric structure. Infect. Immun. 23:287.
19. Pollack, M., J. K. S. Chia, N. L. Koles, M. Miller, and G. Guelde. 1989. Specificity and cross-reactivity of monoclonal antibodies reactive with the core and lipid A regions of bacterial lipopolysaccharide. J. Infect. Dis. 159:168.
20. Oishi, K., N. L. Koles, G. Guelde, and M. Pollack. 1992. Antibacterial and protective properties of monoclonal antibodies reactive with Escherichia coli O111:B4 lipopolysaccharide: relation to antibody isotype and complement-fixing activity. J. Infect. Dis. 165:34.
21. Pier, G. B., N. L. Koles, G. Meluleni, K. Hatano, and M. Pollack. 1994. Specificity and function of murine monoclonal antibodies and immunization-induced human polyclonal antibodies to lipopolysaccharide subtypes of Pseudomonas aeruginosa serogroup 06. Infect. Immun. 62:1137.
22. Chia, J. K. S., M. Pollack, G. Guelde, N. L. Koles, M. Miller, and M. E. Evans. 1989. Lipopolysaccharide (LPS)-reactive monoclonal antibodies fail to inhibit LPS-induced tumor necrosis factor secretion by mouse-derived macrophages. J. Infect. Dis. 159:872.
23. Chia, J. K. S., M. Pollack, D. Avigan, and S. Steinbach. 1986. Functionally distinct monoclonal antibodies reactive with enzymatically active and binding domains of Pseudonwnas aeruginosa toxin A. Infect. Immun. 52:756.
24. 23a. O'Shea, J. J., E. J. Brown, B. E. Seligmann, J. A. Metcalf, M. M. Frank, and J. I. Gallin. 1985. Evidence for distinct intracellular pools of receptors for C3b and C3bi in human neutrophils. J. Immunol. 134:2580.
25. Wahl, L. M., I. M. Katona, R. L. Wilder, C. C. Winter, B. Haraoui, I. Scher, and S. M. Wahl. 1984. Isolation of human mononuclear cell subsets by counterflow centrifugal elutriation (CCE). I. Characterization of B-lymphocyte-, T-lymphocyte-, and monocyte-enriched fractions by flow cylometric analysis. Cell. Immunol. 85:373.
26. Wahl, L. M., and P. D. Smith. 1992. Isolation of monocyte/macrophage populations. In Current Protocols in Immunology. J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, eds. John Wiley and Sons, New York, p. 7.6.1.
27. Wahl, S. M., N. McCartney-Francis, D. A. Hum, P. D. Smith, L. M. Wahl, and I. M. Katona. 1987. Monocyte interleukin 2 receptor gene expression and interleukin 2 augmentation of microbicidal activity. J. Immunol. 139:1342.
28. Ruff, M., and G. Gifford. 1980. Purification and physicochemical characterization of rabbit tumor necrosis factor. J. Immunol. 125:1671.
29. Delude, R. L., M. J. Fenton, R. Savedra Jr., P.-Y. Perera, S. N. Vogel, R. Thieringer, and D. T. Golenbock. 1994. CD14-mediated translocation of nuclear factor κB induced by lipopolysaccharide does not require tyrosine kina.se activity. J. Biol. Chem. 269:22253.
30. Siegel, S. 1956. Nonparametric Statistics for the Behavioral Sciences. McGraw-Hill, New York, p. 127.
31. Delude, R. L., R. Savedra, Jr., S. Yamamoto, and D. T. Golenbock. 1995. Use of CD14 transfected cells to study LPS-antagonist action. Prog. Clin. Biol. Res. 392:487.
32. Gallay, P., C. V. Jongeneel, C. Barras, M. Burnier, J.-D. Baumgartner, M. P. Glauser, and D. Heumann. 1993. Short time exposure to lipopolysaccharide is sufficient to activate human monocytes. J. Immunol. 150:5086.
33. Kirkland, T. N., F. Finley, D. Leturcq, A. Moriarty, J. Lee, R. J. Ulevitch, and P. S. Tobias. 1993. Analysis of lipopolysaccharide binding by CD14. J. Biol. Chem. 268:24818.
34. Delude, R. L., R. Savedra Jr., H. Zhao, R. Thieringer, S. Yamamoto, M. J. Fenton, and D. T. Golenbock. 1995. CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition. Proc. Natl. Acad. Sci. USA 92:9288.
35. Luchi, M., and R. S. Munford. 1993. Binding, internalization, and deacylation of bacterial lipopolysaccharide by human neutrophils. J. Immunol. 151:959.
36. Munford, R. S., and J. M. Dietschy. 1985. Effects of specific antibodies, hormones, and lipoproteins on bacterial lipopolysaccharides injected into the rat. J. Infect. Dis. 152:177.
37. Bacle, F., N. Haeffner-Cavaillon, M. Laude, C. Couturier, and M. D. Kazatchkine. 1990. Induction of IL-I release through stimulation of the C3b/C4b complement receptor type one (CR1, CD35) on human monocytes. J. Immunol. 144: 147.
38. Wright, S. D. 1995. CD14 and innate recognition of bacteria. J. Immunol. 155:6.
39. Fearon, D. T., and R. M. Locksley. 1996. The instructive role of innate immunity in the acquired immune response. Science 272:50.